SBRT Dose for PET-CT Positive Para-Aortic Lymph Nodes
For PET-CT positive para-aortic lymph nodes, deliver 30-45 Gy in 3-5 fractions using SBRT, with the specific dose determined by proximity to organs at risk—use 40 Gy in 5 fractions (BED10 = 72 Gy) as the standard approach when dose constraints allow, or 30 Gy in 3 fractions (BED10 = 48 Gy) when adjacent to critical structures.
Dose Selection Framework
The evidence supports a range-based approach rather than a single prescription:
Standard Dose Regimens
- 40 Gy in 5 fractions is the most commonly reported regimen for para-aortic nodes 12
- 30 Gy in 3 fractions is appropriate for lesions immediately adjacent to bowel, kidneys, or major vessels 1
- 45 Gy in 5 fractions can be used when organs at risk constraints are safely met 3
The biological effective dose (BED10) is critical for tumor control. A BED10 of 90 Gy predicts 90% tumor control probability for para-aortic oligometastases 2. This translates to:
- 40 Gy/5 fractions = BED10 of 72 Gy
- 45 Gy/5 fractions = BED10 of 85.5 Gy
- 30 Gy/3 fractions = BED10 of 48 Gy
Clinical Context Matters
While the guidelines 4 describe SBRT for lung cancer using 6-18 Gy per fraction over 2-8 sessions, para-aortic lymph nodes require modified dosing due to proximity to radiosensitive gastrointestinal organs. The research evidence specifically addressing para-aortic nodes 1, 5, 2 consistently uses lower doses per fraction (7-12 Gy) compared to lung SBRT.
Treatment Planning Considerations
Dose-Limiting Organs at Risk
For para-aortic lymph nodes, the critical structures are:
- Bowel (duodenum, small intestine, colon)
- Kidneys
- Liver
- Bladder
- Spinal cord
Keep bowel D0.5cc below 32 Gy in 5 fractions or 25 Gy in 3 fractions to minimize severe gastrointestinal toxicity 5.
PET-CT Based Target Definition
Use 18F-FDG PET-CT to define the gross tumor volume (GTV), as it identifies metabolically active disease that may be missed on CT alone 6. However, recognize that PET-based GTVs are typically larger than CT-based volumes due to respiratory motion during acquisition 6. The planning target volume (PTV) should expand 3-5 mm from the GTV to account for setup uncertainty 1, 6.
Expected Outcomes
With appropriate dosing:
- Local control: 83-96% at 5 years 1, 2
- Severe toxicity (grade ≥3): 1-2% 1, 2
- Complete metabolic response is achievable in properly selected patients 1
Critical Pitfalls to Avoid
- Do not use lung SBRT doses (e.g., 48-60 Gy in 3-4 fractions) for para-aortic nodes—the proximity to bowel makes this unsafe
- Do not rely on CT alone for target delineation when PET-CT shows metabolically active disease
- Do not exceed bowel dose constraints even if it means reducing target coverage—severe bowel toxicity is life-threatening
- Consider online adaptive planning 3 when available, as it allows isotoxic dose escalation while respecting organ constraints
The dose selection ultimately depends on the specific anatomic relationship between the lymph node and surrounding organs at risk, but 40 Gy in 5 fractions represents the optimal balance between tumor control and toxicity for most para-aortic presentations.